UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Three-step matching algorithm to enhance between-group comparability and minimize confounding in comparative effectiveness studies

Scientific reports, 2022-01, Vol.12 (1), p.214-214, Article 214

2022

Volltextzugriff (PDF)

A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes

Scientific reports, 2021-02, Vol.11 (1), p.4152-4152, Article 4152

2021

Volltextzugriff (PDF)

Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review

Frontiers in endocrinology (Lausanne), 2022-03, Vol.13, p.836365-836365

2022

Volltextzugriff (PDF)

Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study

Cardiovascular diabetology, 2020-06, Vol.19 (1), p.83-10, Article 83

2020

Volltextzugriff (PDF)

Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach

Cardiovascular diabetology, 2024-07, Vol.23 (1), p.1-11, Article 244

2024

Volltextzugriff (PDF)

Longitudinal economic burden of incident complications among metabolic syndrome populations

Cardiovascular diabetology, 2024-07, Vol.23 (1), p.1-10, Article 246

2024

Volltextzugriff (PDF)

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes

Cardiovascular diabetology, 2020-07, Vol.19 (1), p.105-105, Article 105

2020

Volltextzugriff (PDF)

Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review

Cardiovascular diabetology, 2021-01, Vol.20 (1), p.21-10, Article 21

2021

Volltextzugriff (PDF)

Valuing health states of people with type 2 diabetes: Analyses of the nationwide representative linked databases

Journal of diabetes investigation, 2021-09, Vol.12 (9), p.1749-1758

2021

Volltextzugriff (PDF)

Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study

Cardiovascular diabetology, 2023-10, Vol.22 (1), p.1-272, Article 272

2023

Volltextzugriff (PDF)

What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?

Journal of diabetes and its complications, 2018-10, Vol.32 (10), p.911-915

2018

Volltextzugriff (PDF)

Association of ambient air pollution with cardiovascular disease risks in people with type 2 diabetes: a Bayesian spatial survival analysis

Environmental health, 2020-11, Vol.19 (1), p.110-12, Article 110

2020

Volltextzugriff (PDF)

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis

Cardiovascular diabetology, 2020-10, Vol.19 (1), p.172-172, Article 172

2020

Volltextzugriff (PDF)

Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy

International journal of infectious diseases, 2020-02, Vol.91, p.44-49

2020

Volltextzugriff (PDF)

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

Diabetes research and clinical practice, 2022-01, Vol.183, p.109119-109119, Article 109119

2022

Volltextzugriff (PDF)

100 years of Insulin: Why is Insulin So Expensive and What Can be Done to Control Its Cost?

Endocrinology and metabolism clinics of North America, 2021-09, Vol.50 (3), p.e21-e34

2021

Volltextzugriff (PDF)

Cost-effectiveness of implementing the chronic care model for diabetes care in a military population

Journal of diabetes science and technology, 2011-05, Vol.5 (3), p.501-513

2011

Volltextzugriff (PDF)

Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up

Diabetes care, 2020-08, Vol.43 (8), p.1732-1740

2020

Volltextzugriff (PDF)

1932-LB: Cost-Effectiveness of the National Diabetes Prevention Program—A Real-World, Two-Year Prospective Study

Diabetes (New York, N.Y.), 2024-06, Vol.73 (Supplement_1)

2024

Volltextzugriff (PDF)

Impact of Certified Diabetes Educators following Preapproved Protocols on Diabetes Self-Care Behaviors—Results of the REMEDIES 4D Trial

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data

Diabetes research and clinical practice, 2023-04, Vol.198, p.110625-110625, Article 110625

2023

Volltextzugriff (PDF)

Professional Practice Committee

Diabetes care, 2016-01, Vol.39 Suppl 1 (Supplement_1), p.S3-S3

2016

Volltextzugriff (PDF)

Cost-Effectiveness of a Diabetes Self-Management Education and Support Intervention Led by Community Health Workers and Peer Leaders: Projections From the Racial and Ethnic Approaches to Community Health Detroit Trial

Diabetes care, 2021-05, Vol.44 (5), p.1108-1115

2021

Volltextzugriff (PDF)

National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001-2018

Diabetes care, 2022-09, Vol.45 (9), p.2003-2011

2022

Volltextzugriff (PDF)

Health Care Coverage and Glycemic Control in Young Adults With Youth-Onset Type 2 Diabetes: Results From the TODAY2 Study

Diabetes care, 2020-10, Vol.43 (10), p.2469-2477

2020

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(59)
Dissertationen
(1)

Sprache

Englisch
(60)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(44)
Humans
(32)
Diabetes
(31)
Endocrinology & Metabolism
(26)
Diabetes Mellitus
(23)
Female
(20)
Male
(19)
Middle Aged
(17)
Adult
(16)
Type 2 Diabetes
(12)
Diabetes Mellitus, Type 2 - Drug Therapy
(11)
Patients
(11)
Aged
(10)
Cost-Benefit Analysis
(10)
Taiwan - Epidemiology
(10)
Cardiovascular Diseases
(9)
Diabetes Mellitus, Type 2 - Epidemiology
(9)
Insulin
(9)
Cardiovascular Disease
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Three-step matching algorithm to enhance between-group comparability and minimize confounding in comparative effectiveness studies

A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes

Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review

Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study

Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach

Longitudinal economic burden of incident complications among metabolic syndrome populations

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes

Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review

Valuing health states of people with type 2 diabetes: Analyses of the nationwide representative linked databases

Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study

What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?

Association of ambient air pollution with cardiovascular disease risks in people with type 2 diabetes: a Bayesian spatial survival analysis

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis

Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

100 years of Insulin: Why is Insulin So Expensive and What Can be Done to Control Its Cost?

Cost-effectiveness of implementing the chronic care model for diabetes care in a military population

Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up

1932-LB: Cost-Effectiveness of the National Diabetes Prevention Program—A Real-World, Two-Year Prospective Study

Impact of Certified Diabetes Educators following Preapproved Protocols on Diabetes Self-Care Behaviors—Results of the REMEDIES 4D Trial

Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data

Professional Practice Committee

Cost-Effectiveness of a Diabetes Self-Management Education and Support Intervention Led by Community Health Workers and Peer Leaders: Projections From the Racial and Ethnic Approaches to Community Health Detroit Trial

National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001-2018

Health Care Coverage and Glycemic Control in Young Adults With Youth-Onset Type 2 Diabetes: Results From the TODAY2 Study

Suchergebnisse filtern